Taken together, our findings demonstrated for the first time that administration of BR could effectively attenuate colonic inflammation in mice, at least partially, via favorable regulation of anti-oxidative and anti-inflammatory status and inhibition of the TLR4-linked NF-κB signaling pathway. The gene discussed is TLR4; the disease is inflammatory response.